Business Description
OraSure Technologies Inc
NAICS : 339112
SIC : 3841
ISIN : US68554V1089
Share Class Description:
FRA:EP3: Ordinary SharesDescription
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 25.08 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 2.42 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.55 | |||||
| Beneish M-Score | -3.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.9 | |||||
| 3-Year EBITDA Growth Rate | 156.9 | |||||
| 3-Year Book Growth Rate | 1.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | -26.85 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.01 | |||||
| 9-Day RSI | 41.63 | |||||
| 14-Day RSI | 43.52 | |||||
| 6-1 Month Momentum % | -12.73 | |||||
| 12-1 Month Momentum % | -41.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.6 | |||||
| Quick Ratio | 11.2 | |||||
| Cash Ratio | 10.03 | |||||
| Days Inventory | 134.49 | |||||
| Days Sales Outstanding | 62.71 | |||||
| Days Payable | 35.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | 1.69 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.01 | |||||
| Operating Margin % | -1.88 | |||||
| Net Margin % | 5.07 | |||||
| FCF Margin % | 28.46 | |||||
| ROE % | 2.69 | |||||
| ROA % | 2.43 | |||||
| ROIC % | -2.05 | |||||
| ROC (Joel Greenblatt) % | -3.74 | |||||
| ROCE % | -0.97 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.33 | |||||
| Forward PE Ratio | 29.75 | |||||
| PE Ratio without NRI | 15.14 | |||||
| Shiller PE Ratio | 22.74 | |||||
| Price-to-Owner-Earnings | 14.56 | |||||
| PS Ratio | 1.26 | |||||
| PB Ratio | 0.67 | |||||
| Price-to-Tangible-Book | 0.73 | |||||
| Price-to-Free-Cash-Flow | 4.43 | |||||
| Price-to-Operating-Cash-Flow | 4.13 | |||||
| EV-to-EBIT | -3.79 | |||||
| EV-to-EBITDA | 3.48 | |||||
| EV-to-Revenue | 0.07 | |||||
| EV-to-FCF | 0.25 | |||||
| Price-to-Projected-FCF | 1.05 | |||||
| Price-to-Median-PS-Value | 0.38 | |||||
| Price-to-Graham-Number | 0.7 | |||||
| Price-to-Net-Current-Asset-Value | 0.91 | |||||
| Price-to-Net-Cash | 1.18 | |||||
| Earnings Yield (Greenblatt) % | -26.39 | |||||
| FCF Yield % | 22.58 | |||||
| Forward Rate of Return (Yacktman) % | 27.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OraSure Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 205.824 | ||
| EPS (TTM) (€) | 0.139 | ||
| Beta | 1.06 | ||
| Volatility % | 51.81 | ||
| 14-Day RSI | 43.52 | ||
| 14-Day ATR (€) | 0.070856 | ||
| 20-Day SMA (€) | 3.764 | ||
| 12-1 Month Momentum % | -41.82 | ||
| 52-Week Range (€) | 3.52 - 7.5 | ||
| Shares Outstanding (Mil) | 74.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OraSure Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OraSure Technologies Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
OraSure Technologies Inc Frequently Asked Questions
What is OraSure Technologies Inc(FRA:EP3)'s stock price today?
The current price of FRA:EP3 is €3.62. The 52 week high of FRA:EP3 is €7.50 and 52 week low is €3.52.
When is next earnings date of OraSure Technologies Inc(FRA:EP3)?
The next earnings date of OraSure Technologies Inc(FRA:EP3) is 2025-02-27 Est..
Does OraSure Technologies Inc(FRA:EP3) pay dividends? If so, how much?
OraSure Technologies Inc(FRA:EP3) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers